Conference Coverage
about 23 hours ago
Driving Progress Through Collaboration at SABCS5 days ago
ICYMI: Highlights From AACR 2025Latest Content
Dec 19, 2025 | News
Phase 2b Trial Shows Vixarelimab Improves Itch and Lesions in Prurigo Nodularis
AJMC® in the Press, December 19, 2025
Dec 19, 2025
Top 5 Infectious Disease Pieces of 2025
Dec 19, 2025
Canopy’s Remote Therapeutic Monitoring Cuts Infection-Related Hospitalizations by Half in Patients With Blood Cancers
Dec 19, 2025
Study Suggests Adding BTKi to Chemo May Improve Early Outcomes in Richter Transformation in CLL
Dec 18, 2025
Advertisement
Shorts
0:25
Why Fractionated Radiotherapeutic Dosing May Improve Outcomes in LM Treatment: Andrew Brenner, MD
2 days ago
by
Sabrina McCrear(+1 more)
0:41
How Rhenium Nanoliposomes Target Leptomeningeal Metastases: Andrew Brenner, MD
3 days ago
by
Sabrina McCrear(+1 more)
1:11
Understanding LM Therapy Across Breast Cancer Subtypes: Andrew Brenner, MD
4 days ago
by
Sabrina McCrear(+1 more)
0:58
Changes to USAID Affected Worldwide HIV Response: Antonio Urbina, MD
11 days ago
by
Julia Bonavitacola(+1 more)
1:32
Getting Lenacapavir on Insurance Plans Is Key to Uptake: Antonio Urbina, MD
16 days ago
by
Julia Bonavitacola(+1 more)
1:52
DTC Models Offer Promise for Some, but Remain Limited in Scope: Brian Reid, MS
16 days ago
by
Brooke McCormick(+1 more)
0:53
Treatments for Symptom-Driven Conditions Are the Best Fit for DTC Models: Jennifer Graff, PharmD
17 days ago
by
Brooke McCormick(+1 more)
0:37
Oral Pill Removes Barrier to Cholesterol-Lowering Therapy: Ann Marie Navar, MD, PhD
20 days ago
by
Laura Joszt, MA(+1 more)
1:09
Administrative Glitches Could Leave Gaps in Care After Medicaid Work Requirements: Ciara Zachary, PhD, MPH
22 days ago
by
Julia Bonavitacola(+1 more)
1:02
Millions Set to Lose Medicaid Despite Some Exceptions to Work Requirements: William Schpero, PhD, MPhil, MPH
23 days ago
by
Julia Bonavitacola(+1 more)
Center on Health Equity & Access
Start seeing what truly shapes access and learn how you can redefine the landscape.
Podcasts
Center on Health Equity & Access
Continuing Medical Education
Advertisement
All News
Advertisement
Readers of AJMC gravitated to articles on technology, policy, and clinical workflows, reflecting the pursuit of improved quality and responsible spending.
With new treatments, environmental insights, and evolving views on comorbidity shaping patient care, this is the most-viewed psoriasis content of 2025.
Experts at SABCS highlighted the aggressive nature of breast cancer in young women, emphasizing tailored management and support strategies.
Experts advocate for a shift in CKD care towards prevention and maintaining kidney health, emphasizing lifestyle changes and early interventions.
The 2025 American Thoracic Society International Conference brought advancements in pulmonary medicine and highlighted the need for health equity reforms.
Zasocitinib met all primary and secondary end points, showing rapid PASI 75 responses and high rates of skin clearance vs placebo and apremilast.
The FDA approved subcutaneous amivantamab with recombinant human hyaluronidase for EGFR-mutated NSCLC based on the phase 3 PALOMA-3 trial.
Advancements in 2025 in non-Hodgkin lymphoma treatments focused on bringing CAR T-cell therapy and bispecific antibodies into the community setting.
The meeting included new evidence and expert insights on hormone therapy, AI, and the expanding role of GLP-1 therapies in cardiovascular care.
A study using Mendelian randomization found higher BMI and IBD have causal links to hidradenitis suppurativa risk.
Advertisement
Advertisement
Trending on AJMC
1
House Republicans Block Vote on ACA Subsidy Extension
2
Zasocitinib Hits Phase 3 End Points in Plaque Psoriasis
3
Study Suggests Adding BTKi to Chemo May Improve Early Outcomes in Richter Transformation in CLL
4
FDA Approval of Subcutaneous Amivantamab Offers Faster, Safer Option for EGFR-Mutated NSCLC
5
